PEPTIDES IN WASHINGTON
@RobertKennedyJr has been pushing for broader access to certain peptides — and in July 2026, an FDA advisory committee voted in favor of allowing several to move toward broader pharmacy compounding access, including:
BPC-157 • TB-500 • KPV • MOTS-c
The regulatory conversation around peptides is changing fast.
This is only the beginning.
Welcome to the group chat, federal government.
Sources in replies.
@9thIslandai IT IS THE FUTURE!
Imagine a world where disease, cancers, biological deficiencies, aging and so much more can be eradicated by our own biological responses and processes!
So Exciting!
Peptides are short chains of amino acids studied for their role in biological signaling. Different sequences can interact with different pathways, which is why peptide research is so broad and why the science is moving so fast.
This isn’t about guessing.
It’s about understanding the language biology already uses.
Different sequence.
Different signal.
Different pathway.
Different response.
Upgrade the biology.
Learn the signal.
PACO
Research-focused. Quality-driven. Built for the next era of wellness.
For thousands of years horses were seen as the pinnacle of transportation.
Henry Ford himself said, "if I would have asked people what they wanted, they would have said faster horses."
Nobody saw what he saw.
Today there is an entire infrastructure built around automobiles. Today you can't really get around without a car.
Medicine is in that same moment right now. For decades, the default answer has been: manage the symptom, take it for life, hope the side effects stay tolerable.
Peptides are the early automobile.
Not magic.
Not a replacement for every drug.
But a vision of the future of health and wellness.
• 𝟴𝟭,𝟴𝟬𝟲 𝗼𝗽𝗶𝗼𝗶𝗱 𝗱𝗲𝗮𝘁𝗵𝘀. In 2022, that many U.S. overdose deaths involved an opioid, not all drugs. CDC, March 2024: https://t.co/iGJ8l3IHZd
• 𝗜𝘁 𝘀𝘁𝗮𝗿𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝘀. Deaths began rising in the late 1990s after opioid painkillers were prescribed much more widely. CDC: https://t.co/EbwXclyf9N
• 𝟱𝟯% 𝗼𝗳 𝗰𝗮𝗹𝗼𝗿𝗶𝗲𝘀. From August 2021 to August 2023, ultra-processed food was 53% of daily calories for American adults. CDC: https://t.co/ByOMNO8OAZ
• 𝟰𝟬.𝟯% 𝗵𝗮𝗱 𝗼𝗯𝗲𝘀𝗶𝘁𝘆. Measured in person, that share of adults had obesity in the same window. CDC: https://t.co/fiJmVpNdbm
• 𝗔𝗻𝘅𝗶𝗲𝘁𝘆 𝗮𝗻𝗱 𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗿𝗼𝘀𝗲. From 2019 to 2022, recent anxiety symptoms went from 15.6% to 18.2%, and depression symptoms from 18.5% to 21.4%. CDC: https://t.co/kDvViNLCp5
• 𝗔𝗯𝗼𝘂𝘁 𝟯𝟲%, 𝗯𝘆 𝗽𝗼𝗹𝗹. Gallup's own survey, not the CDC exam, put self-reported obesity at 39.9% in 2022 and about 36% so far in 2026. The page prints both 36.4% and 36.8%. https://t.co/ZiZB0WYZOi
• 𝟭𝟭% 𝗼𝗻 𝗮 𝗚𝗟𝗣-𝟭. In that same Gallup survey, 11% of adults said they were currently taking Ozempic, Wegovy, Saxenda, Mounjaro, or Zepbound. Gallup does not prove those drugs caused the drop. Same page.
• 𝗡𝗲𝗮𝗿𝗹𝘆 𝟭𝟬𝟬 𝗽𝗲𝗽𝘁𝗶𝗱𝗲 𝗱𝗿𝘂𝗴𝘀. A 2025 review counts nearly 100 approved worldwide, and 38 in late-stage trials. The "over 150" line does not hold. https://t.co/MLOCYPzH6Y
• 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟭𝟭, 𝟭𝟵𝟮𝟮. That Wednesday in Toronto, the first extract barely helped. The one that worked started January 23. https://t.co/jtrVlT4OKe
For post: Peptides took 100 years.
What else does the body already know how to build, and who decides when we find out?
https://t.co/JCGiQ8N1PI
Research use only. Not medical advice.
Sources in the reply.